Terms: = Skin cancer AND MYD88, Q99836, MYD88D, 4615 AND Treatment
25 results:
1. Heterocyclic-Modified Imidazoquinoline Derivatives: Selective TLR7 Agonist Regulates Tumor Microenvironment against Melanoma.
Ou J; Zheng L; Chen Y; Fu Q; Tan L; Liang E; Huang L; Pan Y; Ke J; Chen Z; Cheng K
J Med Chem; 2024 Mar; 67(5):3321-3338. PubMed ID: 38363069
[TBL] [Abstract] [Full Text] [Related]
2. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract] [Full Text] [Related]
3. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
[TBL] [Abstract] [Full Text] [Related]
4. Glycoside oleandrin downregulates toll-like receptor pathway genes and associated miRNAs in human melanoma cells.
Eroğlu Güneş C; Seçer Çelik F; Seçme M; Elmas L; Dodurga Y; Kurar E
Gene; 2022 Nov; 843():146805. PubMed ID: 35964872
[TBL] [Abstract] [Full Text] [Related]
5. Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia.
Treon SP; Meid K; Hunter ZR; Flynn CA; Sarosiek SR; Leventoff CR; White TP; Cao Y; Roccaro AM; Sacco A; Demos MG; Guerrera ML; Kofides A; Liu X; Xu L; Patterson CJ; Munshi M; Tsakmaklis N; Yang G; Ghobrial IM; Branagan AR; Castillo JJ
Blood; 2021 Oct; 138(17):1535-1539. PubMed ID: 34289017
[TBL] [Abstract] [Full Text] [Related]
6. A myd88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.
Tartey S; Neale G; Vogel P; Malireddi RKS; Kanneganti TD
Cancer Res; 2021 May; 81(9):2358-2372. PubMed ID: 33619117
[TBL] [Abstract] [Full Text] [Related]
7. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
[TBL] [Abstract] [Full Text] [Related]
8. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease.
Patel SS; Acharya A; Ray RS; Agrawal R; Raghuwanshi R; Jain P
Crit Rev Food Sci Nutr; 2020; 60(6):887-939. PubMed ID: 30632782
[TBL] [Abstract] [Full Text] [Related]
9. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract] [Full Text] [Related]
10. Liquiritin suppresses UVB‑induced skin injury through prevention of inflammation, oxidative stress and apoptosis through the TLR4/myd88/NF‑κB and MAPK/caspase signaling pathways.
Li XQ; Cai LM; Liu J; Ma YL; Kong YH; Li H; Jiang M
Int J Mol Med; 2018 Sep; 42(3):1445-1459. PubMed ID: 29901082
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy.
Fox LC; Yannakou CK; Ryland G; Lade S; Dickinson M; Campbell BA; Prince HM
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899297
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract] [Full Text] [Related]
13. A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.
Beylot-Barry M; Mermin D; Maillard A; Bouabdallah R; Bonnet N; Duval-Modeste AB; Mortier L; Ingen-Housz-Oro S; Ram-Wolff C; Barete S; Dalle S; Maubec E; Quereux G; Templier I; Bagot M; Grange F; Joly P; Vergier B; Vially PJ; Gros A; Pham-Ledard A; Frison E; Merlio JP
J Invest Dermatol; 2018 Sep; 138(9):1982-1989. PubMed ID: 29596904
[TBL] [Abstract] [Full Text] [Related]
14. The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.
Pan W; Zhu S; Qu K; Meeth K; Cheng J; He K; Ma H; Liao Y; Wen X; Roden C; Tobiasova Z; Wei Z; Zhao J; Liu J; Zheng J; Guo B; Khan SA; Bosenberg M; Flavell RA; Lu J
Immunity; 2017 Aug; 47(2):284-297.e5. PubMed ID: 28813659
[TBL] [Abstract] [Full Text] [Related]
15. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP
J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469
[TBL] [Abstract] [Full Text] [Related]
16. Ultraviolet radiation signaling through TLR4/myd88 constrains DNA repair and plays a role in cutaneous immunosuppression.
Harberts E; Zhou H; Fishelevich R; Liu J; Gaspari AA
J Immunol; 2015 Apr; 194(7):3127-35. PubMed ID: 25716994
[TBL] [Abstract] [Full Text] [Related]
17. Toll-like receptor 4 signaling promotes the migration of human melanoma cells.
Takazawa Y; Kiniwa Y; Ogawa E; Uchiyama A; Ashida A; Uhara H; Goto Y; Okuyama R
Tohoku J Exp Med; 2014 Sep; 234(1):57-65. PubMed ID: 25175033
[TBL] [Abstract] [Full Text] [Related]
18. High frequency and clinical prognostic value of myd88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effects.
Crain B; Yao S; Keophilaone V; Promessi V; Kang M; Barberis A; Maj R; Mura E; Passini N; Holldack J; Ochoa R; Cottam HB; Carson DA; Hayashi T
Eur J Dermatol; 2013; 23(5):618-28. PubMed ID: 24225049
[TBL] [Abstract] [Full Text] [Related]
20. Epidermal EGFR controls cutaneous host defense and prevents inflammation.
Lichtenberger BM; Gerber PA; Holcmann M; Buhren BA; Amberg N; Smolle V; Schrumpf H; Boelke E; Ansari P; Mackenzie C; Wollenberg A; Kislat A; Fischer JW; Röck K; Harder J; Schröder JM; Homey B; Sibilia M
Sci Transl Med; 2013 Aug; 5(199):199ra111. PubMed ID: 23966300
[TBL] [Abstract] [Full Text] [Related]
[Next]
